Evaluation of three methods of platelet labelling

Area of Science:

• Biomedical Engineering
• Hematology
• Medical Imaging

Background:

• Platelet kinetics studies require viable, labeled platelets.
• Existing commercial kits for 111In-oxinate labeling may affect platelet function.

Purpose of the Study:

• To evaluate the in vitro and in vivo performance of two commercial platelet labeling methods.
• To develop and validate an optimized laboratory method for platelet labeling.

Main Methods:

• In vitro platelet aggregation tests were used to assess viability after labeling.
• In vivo studies in patients undergoing peripheral bypass surgery evaluated platelet half-life and graft accumulation.
• A new labeling method was developed and optimized in the laboratory.

Main Results:

• The Mallinckrodt labeling method reduced platelet aggregation capacity.
• The Amersham method showed normal in vitro aggregation but poor in vivo results.
• The optimized laboratory method yielded good in vitro and in vivo performance.

Conclusions:

• Commercial platelet labeling kits can compromise platelet function.
• An optimized laboratory method is necessary for reliable platelet kinetic studies.
• The developed method shows promise for clinical application in assessing platelet behavior.